Journal Article10.1007/S12098-016-2038-X
Common Variable Immunodeficiency.
Biman Saikia,Sudhir Gupta +1 more
126
TL;DR: Immunologists and other clinicians in India and other South East Asian countries need to be aware of CVID so that early diagnosis can be made, as currently, majority of these patients still go undiagnosed.
read more
Abstract: Common variable immunodeficiency (CVID) is the most common primary immunodeficiency of young adolescents and adults which also affects the children. The disease remains largely under-diagnosed in India and Southeast Asian countries. Although in majority of cases it is sporadic, disease may be inherited in a autosomal recessive pattern and rarely, in autosomal dominant pattern. Patients, in addition to frequent sino-pulmonary infections, are also susceptible to various autoimmune diseases and malignancy, predominantly lymphoma and leukemia. Other characteristic lesions include lymphocytic and granulomatous interstitial lung disease, and nodular lymphoid hyperplasia of gut. Diagnosis requires reduced levels of at least two immunoglobulin isotypes: IgG with IgA and/or IgM and impaired specific antibody response to vaccines. A number of gene mutations have been described in CVID; however, these genetic alterations account for less than 20% of cases of CVID. Flow cytometry aptly demonstrates a disturbed B cell homeostasis with reduced or absent memory B cells and increased CD21(low) B cells and transitional B cell populations. Approximately one-third of patients with CVID also display T cell functional defects. Immunoglobulin therapy remains the mainstay of treatment. Immunologists and other clinicians in India and other South East Asian countries need to be aware of CVID so that early diagnosis can be made, as currently, majority of these patients still go undiagnosed.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
International consensus document (icon): common variable immunodeficiency disorders
Francisco A. Bonilla,Isil Barlan,Helen Chapel,Beatriz Tavares Costa-Carvalho,Charlotte Cunningham-Rundles,M. Teresa de la Morena,Francisco J. Espinosa-Rosales,Lennart Hammarström,Shigeaki Nonoyama,Isabella Quinti,John M. Routes,Mimi L.K. Tang,Klaus Warnatz +12 more
TL;DR: The International Collaboration in Asthma, Allergy and Immunology initiated an international coalition among the American Academy of Allergy, Asthma & Immunology; the European Academy of allergy and Clinical Immunology, and the World Allergy Organization on common variable immunodeficiency.
Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond.
Guillem de Valles-Ibáñez,Ana Esteve-Solé,Mónica Piquer,E. Azucena González-Navarro,Jessica Hernandez-Rodriguez,Hafid Laayouni,Eva González-Roca,A.M. Plaza-Martín,Angela Deyà-Martínez,Andrea Martín-Nalda,Mónica Martínez-Gallo,Marina Garcia-Prat,Lucía del Pino-Molina,Ivon Cuscó,Marta Codina-Solà,Laura Batlle-Masó,Manuel Solís-Moruno,Tomas Marques-Bonet,Elena Bosch,Eduardo López-Granados,Juan I. Aróstegui,Pere Soler-Palacín,Roger Colobran,Jordi Yagüe,Laia Alsina,Manel Juan,Ferran Casals +26 more
TL;DR: This work explores the possibility of CVID being originated by an oligogenic model with the presence of heterozygous mutations in interacting proteins or by the accumulation of detrimental variants in particular immunological pathways, as well as performs association tests to detect association with rare genetic functional variation in the CVID cohort compared to healthy controls.
Common Variable Immunodeficiency: Epidemiology, Pathogenesis, Clinical Manifestations, Diagnosis, Classification, and Management
Reza Yazdani,Sima Habibi,Laleh Sharifi,Gholamreza Azizi,Hassan Abolhassani,Hassan Abolhassani,Peter Olbrich,Asghar Aghamohammadi +7 more
TL;DR: This review aims to discuss different aspects of CVID including epidemiology, pathogenesis, symptoms, diagnosis, classifications and management of the disease.
Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.
Mathieu Amand,Gilles Iserentant,Aurélie Poli,Marwan Sleiman,Virginie Fievez,Isaura Pilar Sánchez,Nicolas Sauvageot,Tatiana Michel,Nassera Aouali,Bassam Janji,Claudia M. Trujillo-Vargas,Carole Seguin-Devaux,Jacques Zimmer +12 more
TL;DR: The phenotype of the CD56dimCD16dim population was differentially affected by HIV-1 infection as compared to the other NK cell subsets and only partly restored to normal by antiretroviral therapy, and the population was identified in various organs of immunodeficient mice with a human immune system reconstituted from human cord blood stem cells.
Overview of infections in the immunocompromised host.
Lesia K. Dropulic,Howard M. Lederman +1 more
- 01 Jan 2009
TL;DR: An approach to laboratory screening for a suspected immunodeficiency is presented and specific defects in the components of the integrated system of physical barriers and of innate and adaptive immunity that contributes to host defense are presented.
95
References
Common variable immunodeficiency: clinical and immunological features of 248 patients
TL;DR: In this article, the authors describe the clinical and immunological status of 248 consecutively referred CVI patients of age range 3-79 years who have been followed for a period of 1-25 years.
1.5K
Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015
Capucine Picard,Waleed Al-Herz,Aziz Bousfiha,Jean-Laurent Casanova,Talal A. Chatila,Mary Ellen Conley,Charlotte Cunningham-Rundles,Amos Etzioni,Steven M. Holland,Christoph Klein,Shigeaki Nonoyama,Hans D. Ochs,Eric Oksenhendler,Jennifer M. Puck,Kathleen E. Sullivan,Mimi L.K. Tang,Mimi L.K. Tang,José Luis Franco,H. Bobby Gaspar +18 more
TL;DR: The most up-to-date catalogue of all known and published primary immunodeficiencies and acts as a current reference of the knowledge of these conditions and is an important aid for the genetic and molecular diagnosis of patients with these rare diseases.
Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency
Waleed Al-Herz,Aziz Bousfiha,Jean-Laurent Casanova,Jean-Laurent Casanova,Helen Chapel,Mary Ellen Conley,Mary Ellen Conley,Charlotte Cunningham-Rundles,Amos Etzioni,Alain Fischer,José Luis Franco,Raif S. Geha,Lennart Hammarström,Shigeaki Nonoyama,Luigi D. Notarangelo,Luigi D. Notarangelo,Hans D. Ochs,Jennifer M. Puck,Chaim M. Roifman,Reinhard Seger,Mimi L.K. Tang,Mimi L.K. Tang +21 more
TL;DR: The updated classification of primary immunodeficiencies (PIDs) compiled by the Expert Committee of the International Union of Immunological Societies acts as a current reference of the knowledge of these conditions and is an important aid for the molecular diagnosis of patients with these rare diseases.
Common variable immunodeficiency disorders: division into distinct clinical phenotypes
Helen Chapel,M Lucas,Martin Lee,Janne Björkander,David Webster,Bodo Grimbacher,Bodo Grimbacher,Claire Fieschi,Vojtech Thon,M. R. Abedi,M. R. Abedi,Lennart Hammarström +11 more
TL;DR: The European Common Variable Immunodeficiency Disorders registry was started in 1996 to define distinct clinical phenotypes and determine overlap within individual patients and analysis of mortality showed a considerable reduction in the last 15 years and that different phenotypes were associated with different survival times.
788
Clinical picture and treatment of 2212 patients with common variable immunodeficiency
Benjamin Gathmann,Nizar Mahlaoui,Laurence Gérard,Eric Oksenhendler,Klaus Warnatz,I. Schulze,Gerhard Kindle,Taco W. Kuijpers,Rachel T. van Beem,David Sanchez-Migallon Guzman,Sarita Workman,Pere Soler-Palacín,Javier de Gracia,Torsten Witte,Reinhold E. Schmidt,Jiri Litzman,Eva Hlaváčková,Vojtech Thon,Michael Borte,Stephan Borte,Stephan Borte,Dinakantha S. Kumararatne,Conleth Feighery,Hilary Longhurst,Matthew Helbert,Anna Szaflarska,Anna Sediva,Bernd H. Belohradsky,Alison Jones,Ulrich Baumann,Isabelle Meyts,Necil Kutukculer,Per Wågström,Nermeen Galal,Joachim Roesler,Evangelia Farmaki,Natalia Zinovieva,Peter Ciznar,Efimia Papadopoulou-Alataki,Kirsten Bienemann,Sirje Velbri,Z. Panahloo,Bodo Grimbacher,Bodo Grimbacher +43 more
TL;DR: In this article, the authors analyzed the clinical presentation, association between clinical features, and differences and effects of immunoglobulin treatment in Europe for Common Variable Immunodeficiency (CVID) patients.
580